NVAX
Price
$5.58
Change
-$0.01 (-0.18%)
Updated
Dec 6, 6:59 PM EST
83 days until earnings call
VERV
Price
$12.49
Change
+$0.92 (+7.95%)
Updated
Dec 6, 6:59 PM EST
96 days until earnings call
Ad is loading...

Compare predictions NVAX vs VERV

Header iconNVAX vs VERV Comparison
Open Charts NVAX vs VERVBanner chart's image
Novavax
Price$5.58
Change-$0.01 (-0.18%)
Volume$3.36M
CapitalizationN/A
Verve Therapeutics
Price$12.49
Change+$0.92 (+7.95%)
Volume$1.54M
CapitalizationN/A
View a ticker or compare two or three
NVAX vs VERV Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
NVAX vs. VERV commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and VERV is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (NVAX: $5.58 vs. VERV: $12.49)
Brand notoriety: NVAX: Notable vs. VERV: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 48% vs. VERV: 86%
Market capitalization -- NVAX: $648.59M vs. VERV: $736.98M
NVAX [@Biotechnology] is valued at $648.59M. VERV’s [@Biotechnology] market capitalization is $736.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • NVAX’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • NVAX’s TA Score: 6 bullish, 2 bearish.
  • VERV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NVAX is a better buy in the short-term than VERV.

Price Growth

NVAX (@Biotechnology) experienced а +0.36% price change this week, while VERV (@Biotechnology) price change was +11.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.57%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +27.93%.

Reported Earning Dates

NVAX is expected to report earnings on Feb 27, 2024.

VERV is expected to report earnings on Mar 11, 2024.

Industries' Descriptions

@Biotechnology (+6.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERV($737M) has a higher market cap than NVAX($649M). VERV YTD gains are higher at: -35.452 vs. NVAX (-45.720). VERV has higher annual earnings (EBITDA): -212.02M vs. NVAX (-498.29M). NVAX has more cash in the bank: 651M vs. VERV (485M). VERV has less debt than NVAX: VERV (76.8M) vs NVAX (222M). NVAX has higher revenues than VERV: NVAX (974M) vs VERV (7.63M).
NVAXVERVNVAX / VERV
Capitalization649M737M88%
EBITDA-498.29M-212.02M235%
Gain YTD-45.720-35.452129%
P/E RatioN/A3.16-
Revenue974M7.63M12,772%
Total Cash651M485M134%
Total Debt222M76.8M289%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXVERV
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILIX50.61N/A
N/A
TIAA-CREF Large-Cap Gr Idx Instl
FASPX45.86N/A
N/A
Fidelity Advisor® Value Strategies M
VSSCX36.55N/A
N/A
JPMorgan Small Cap Sustainable Ldrs R5
IEDZX12.97N/A
N/A
Voya Large Cap Value R6
IGNIX16.19N/A
N/A
Delaware Ivy Natural Resources I

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+7.95%
BEAM - VERV
62%
Loosely correlated
+1.52%
CRSP - VERV
61%
Loosely correlated
+0.76%
NTLA - VERV
54%
Loosely correlated
-0.07%
MDGL - VERV
52%
Loosely correlated
+0.56%
PGEN - VERV
50%
Loosely correlated
-5.66%
More